NMRA Earnings

Quarterly EPS
$-0.45
Q3 2024
$-0.37
Q4 2024
$-0.42
Q1 2025
$-0.33
Q2 2025
$-0.35
Q3 2025
$-0.35
Q4 2025
$-0.30
Q1 2026
$-0.23
Q2 2026
Latest RevenueN/A
Latest Net Income-43082000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.230-43082000+30.3%
Q1 2026-$0.300-53458000+28.6%
Q4 2025-$0.350-59450000+5.4%
Q3 2025-$0.350-56755000+22.2%
Q2 2025-$0.330-52731000+10.8%
Q1 2025-$0.420-67992000-23.5%
Q4 2024-$0.370-58819000+47.9%
Q3 2024-$0.450-72547000+60.5%
Q2 2024-$0.370-58700000
Q1 2024-$0.340-53721000
Q4 2023-$0.710-108730000
Q3 2023-$1.140-53027000
Neumora Therapeutics (NMRA) — Earnings